These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5506243)

  • 1. Changes in serum glucose and free fatty acids after administration of tolbutamide to obese women.
    Harell A; Oberman Z; Herzberg M; Laurin L
    Isr J Med Sci; 1970; 6(2):304-8. PubMed ID: 5506243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Levels of basal insulinemia and changes of the plasmatic concentration of nonesterified fatty acids (NEFA) and of blood sugar after administration of tolbutamide in obese children].
    Iafusco F; Pierantoni G; Stoppoloni G; Pacelli V
    Pediatria (Napoli); 1967; 75(5):780-8. PubMed ID: 5603123
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in serum cortisol, glucose and free fatty acid levels during tolbutamide-induced hypoglycemia in obese women.
    Laurian L; Oberman Z; Harel A; Cordova T; Herzberg M
    Isr J Med Sci; 1972 Nov; 8(11):1817-22. PubMed ID: 4567132
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
    Kirti S; Dutta PK; Vaishnava H; Singh RB
    J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of tolbutamide on blood glucose, plasma free fatty acids and insulin in normal and obese children.
    Weber B; Helge H; Sihombing G; Werner E
    Isr J Med Sci; 1968; 4(2):290-7. PubMed ID: 5650058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of aminophylline, a phosphodiesterase inhibitor on somatotropin secretion after intravenous tolbutamide loading in obese subjects].
    Carducci Artenisio A; Ragonese F; Alibrando S; Giardina S; Corsi V
    Boll Soc Ital Biol Sper; 1973 Jul; 49(14):876-82. PubMed ID: 4367154
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of the plasmatic STH level in obese subjects following endovenous administration of tolbutamide].
    Carducci Artenisio A; Albanese MC; Allegra V; Alibrando S; Corsi V
    Boll Soc Ital Biol Sper; 1972 May; 48(9):209-12. PubMed ID: 5070090
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in plasma cortisol, free fatty acids and glucose during tolbutamide-induced hypoglycemia. Further observations.
    Laurian L; Oberman Z; Harell A; Yaskolka H; Herzberg M
    Isr J Med Sci; 1973; 9(11):1585-8. PubMed ID: 4778405
    [No Abstract]   [Full Text] [Related]  

  • 9. [Obesity and diabetes. II. Tolbutamide intravenous test in obese patients].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1970 May; 31(2):88-99. PubMed ID: 5470191
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
    Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
    Verh Dtsch Ges Inn Med; 1971; 77():556-9. PubMed ID: 5155896
    [No Abstract]   [Full Text] [Related]  

  • 11. [The behavior of glucose, pyruvic acid and nonesterified fatty acids following i.v. tolbutamide loading in fatty liver].
    Teichmann W; Bchardt U
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):217-20. PubMed ID: 5732400
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the plasmatic concentration of non-esterified fatty acids during the intravenous tolbutamide test in the aged].
    Locatelli GR; Piotti LE
    G Gerontol; 1966 Oct; 14(10):961-8. PubMed ID: 5993793
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
    Ulrich E; Frank I; Kujat G; Müller G; Seige K
    Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in plasma cortisol, glucose and free fatty acids after caffeine ingestion in obese women.
    Oberman Z; Herzberg M; Jaskolka H; Harell A; Hoerer E; Laurian L
    Isr J Med Sci; 1975 Jan; 11(1):33-6. PubMed ID: 1116938
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of heparin on HGH secretion after intravenous administration of tolbutamide in normal subjects].
    Ragonese F; Melluso R; Campisi R; Carducci Artenisio A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1975-9. PubMed ID: 1231882
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of blood sugar and blood nonesterified fatty acids in old primiparas and in pluriparas].
    Sani G; Floris F
    Riv Ital Ginecol; 1969 Mar; 53(3):175-201. PubMed ID: 5405777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolic changes induced by intravenous administration of sorbitol to healthy subjects and the effect of tolbutamide and butylbiguanide].
    Brodan V; Kuhn E; Válek J; Slabochová Z; Brodanová M
    Cas Lek Cesk; 1973 May; 112(18):549-55. PubMed ID: 4701731
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of the glycoregulation in the obese child.
    Loeb H; Ooms HA; Wolter R; Brunet N
    Pediatrics; 1970 Aug; 46(2):297-301. PubMed ID: 5432159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of the tolbutamide test on plasmatic concentration of NEFA in the climacteric].
    Quinto P; Orlandi C
    Minerva Ginecol; 1968 Apr; 20(8):678-87. PubMed ID: 5738756
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in plasma free fatty acids after glucose loading in obese and non-obese children].
    Zimányi I; Tibor L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):313-7. PubMed ID: 5525404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.